The growing number of cancer survivors in the EU is a tribute to the success of advances in diagnosis and treatment. The latest scientific research and data account for over 20 million cancer survivors in Europe and, for many, it then becomes necessary to overcome the psychological impact of their treatments, workplace marginalization and access to financial services such as mortgages and loans. 

Thanks to medicine’s tremendous progress, cancer is no longer a death sentence. It is the duty of European and national policymakers ensure that cancer survivors never again have to pay twice for their disease.  

The Right to Be Forgotten has been named as one of the European Commission’s priorities in the Beating Cancer Plan and is operating under the supervision of Dr. Françoise Meunier, a member of The Royal Academies of Medicine of Belgium, the ECPC’s Scientific Committee and the Chair of the Cancer Survivorship Committee of the European Academy of Cancer Sciences (EACS).